ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs MXN
20.3959
-0.16%
Brent Oil
74.335
-0.58%
Bitcoin
98,850.48
0.82%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Momenta Pharmaceuticals Inc (MNTA)

  7. Momenta Pharmaceuticals Inc (MNTA) Noticias

MNTA

Momenta Pharmaceuticals (MNTA)

Momenta Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MNTA
FechaHoraFuenteTítuloSímboloCompañía
10/11/202009:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
13/10/202007:15Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202016:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202015:55Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202015:31Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202015:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202008:55Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202008:00Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202007:57Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202007:44GlobeNewswire Inc.Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
25/09/202016:47PR Newswire (US)Chesapeake Utilities to Join S&P SmallCap 600NASDAQ:MNTAMomenta Pharmaceuticals Inc
15/09/202007:00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
02/09/202005:54Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202014:18Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202002:02Dow Jones NewsJ&J, Biotech Firm In $6.5 Billion Deal J&J Agrees to Buy Biotech Company -- WSJNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202015:26Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202006:21Dow Jones NewsJohnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 BillionNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202005:35GlobeNewswire Inc.Momenta Enters Definitive Agreement with Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202015:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202006:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
03/08/202006:30GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of Second Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
28/07/202006:15GlobeNewswire Inc.Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFNNASDAQ:MNTAMomenta Pharmaceuticals Inc
15/06/202006:05GlobeNewswire Inc.Momenta Pharmaceuticals Announces Positive Topline Data from Interim Analysis of Phase 2 Vivacity-MG Study of Nipocalimab (M2...NASDAQ:MNTAMomenta Pharmaceuticals Inc
07/05/202006:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
06/05/202009:04Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MNTAMomenta Pharmaceuticals Inc
24/04/202016:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
23/04/202007:00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of First Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
02/04/202006:30GlobeNewswire Inc.Momenta Provides Corporate Update Amid COVID-19 PandemicNASDAQ:MNTAMomenta Pharmaceuticals Inc
27/02/202015:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
26/02/202006:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MNTA

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
NYSE
BAC
Bank of America
NASDAQ
MSFT
Microsoft
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
GOOGL
Alphabet
COIN
ADAUSD
Cardano
NASDAQ
AAPL
Apple
COIN
XRPUSD
Ripple
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados